Mastic oil nasal spray with low-dose steroid for chronic sinusitis
Part of Ear, nose & throat clinical trials.
This study tests a nasal spray made from mastic oil combined with a lower dose of a standard steroid medication (mometasone) for people with chronic sinusitis. It aims to see if this combination is effective in reducing symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have chronic sinusitis (with or without nasal polyps) and a doctor's recommendation for a steroid nasal spray.
- You must be willing to attend follow-up visits and follow the study plan.
- You cannot have cancer, or be pregnant or breastfeeding.
- You cannot have conditions that weaken your immune system or take drugs/alcohol that might affect your participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a special way of using budesonide (a steroid) as nose drops can improve your sense of smell. It's for people with chronic sinusitis and smell loss, and aims to see if this treatment can help restore some ability to smell.
This study tests a special nose dressing that slowly releases a steroid to reduce inflammation and improve healing after sinus surgery for chronic sinusitis with or without nasal polyps.
This trial tests a nasal spray called VVN432 in healthy volunteers and people with chronic sinusitis. It checks if the spray is safe and how the body processes it.
This study looks at how different sinus treatments affect people with cystic fibrosis who are taking modern modulator therapy. It aims to understand which rinses work best for chronic sinus problems.
This trial tests whether a new form of steroid (triamcinolone) delivered in tiny capsules can improve healing after common nasal surgeries for chronic sinusitis or nasal polyps.
This trial tests a nasal spray called Bactorinol combined with a lower dose of a standard steroid (mometasone) to treat chronic sinusitis. It aims to see if the combination reduces symptoms and is safe and well-tolerated.
Hear when a new Chronic Rhinosinusitis (CRS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.